Homocysteine as a risk factor for cardiovascular disease

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Medicine
• Nutritional Science

Background:

• Homocysteine is an amino acid implicated in vascular endothelium damage and thrombosis.
• Elevated homocysteine levels (hyperhomocysteinemia) are linked to atherosclerotic vascular disease.
• Primary causes include genetic defects in cystathionine B-synthase and deficiencies in vitamin B12 or folate.

Purpose of the Study:

• To review the role of homocysteine in vascular pathology.
• To discuss the causes and risk factors associated with hyperhomocysteinemia.
• To evaluate the potential of dietary supplementation in managing homocysteine levels and vascular risk.

Main Methods:

• Literature review and synthesis of existing research on homocysteine metabolism and vascular disease.
• Analysis of the relationship between hyperhomocysteinemia and established cardiovascular risk factors.
• Examination of the efficacy of nutritional interventions for reducing homocysteine.

Main Results:

• Homocysteine damages the vascular endothelium and promotes blood clot formation.
• Hyperhomocysteinemia is associated with atherosclerotic vascular disease, with potential interactions with smoking, hyperlipidemia, and hypertension.
• Dietary supplementation with vitamin B12 and folate effectively reduces homocysteine levels.

Conclusions:

• Hyperhomocysteinemia is a significant risk factor for vascular disease.
• Simple nutritional interventions, such as vitamin B12 and folate supplementation, can lower homocysteine levels.
• These measures may offer a strategy to mitigate vascular disease risk in affected individuals.